Oncotarget

Vol 10, No 64

December 3, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 64 of Oncotarget features Figure 5, "In vivo and ex-vivo growth kinetics of B6CaP," by Simons, et al.

Table of Contents

Research Papers

A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host

A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host

https://doi.org/10.18632/oncotarget.27317

Brian W. Simons, Vishal Kothari, Benjamin Benzon, Kamyar Ghabili, Robert Hughes, Jelani C. Zarif, Ashley E. Ross, Paula J. Hurley,  and Edward M. Schaeffer
6845-6854
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a

https://doi.org/10.18632/oncotarget.27325

Sweta Sikder, Sujata Kumari, Manoj Kumar, Shrinka Sen, Namrata Bora Singhal, Srikumar Chellappan, Mukul Godbole, Pratik Chandrani, Amit Dutt, Kodaganur S. Gopinath,  and Tapas K. Kundu
6855-6869
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

BRAFV600E-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma

https://doi.org/10.18632/oncotarget.27326

M. Herman Chui, Susanne K. Kjaer, Kirsten Frederiksen, Charlotte G. Hannibal, Tian-Li Wang, Russell Vang,  and Ie-Ming Shih
6870-6878
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study

Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study

https://doi.org/10.18632/oncotarget.27347

Luana Mota Martins, Carla Solange de Melo Escorcio Dourado, Larysse Maira Campos-Verdes, Fabiane Araújo Sampaio, Camila Maria Simplício Revoredo, Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, Elmo de Jesus Nery Junior, Lucia Maria do Rego-Medeiros, Luiz Henrique Gebrim, Francisco Adelton Alves-Ribeiro, Gilmara Péres Rodrigues, Diego Cipriano Chagas, Dilina do Nascimento Marreiro,  and Benedito Borges da Silva
6879-6884
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Survival correlation of immune response in human cancers

Survival correlation of immune response in human cancers

https://doi.org/10.18632/oncotarget.27360

Yuexin Liu
6885-6897
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Reviews

A way forward for cancer prevention therapy: personalized risk assessment

A way forward for cancer prevention therapy: personalized risk assessment

https://doi.org/10.18632/oncotarget.27365

Zhenzhen Zhang, Jeffrey Bien, Motomi Mori, Sonali Jindal,  and Raymond Bergan
6898-6912
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC